Tuberculosis of intrathoracic lymph nodes
Chapter 1:Certain infectious and parasitic diseases
ICD-10 A15.4 is a billable code used to indicate a diagnosis of tuberculosis of intrathoracic lymph nodes.
Tuberculosis of intrathoracic lymph nodes is a form of extrapulmonary tuberculosis where the lymph nodes located within the thoracic cavity become infected with Mycobacterium tuberculosis. This condition often presents with symptoms such as persistent cough, fever, night sweats, and weight loss. Diagnosis typically involves imaging studies like chest X-rays or CT scans, which may reveal enlarged lymph nodes, and microbiological tests such as sputum smear and culture, or lymph node biopsy. Treatment usually consists of a multi-drug regimen including isoniazid, rifampin, ethambutol, and pyrazinamide, which must be adhered to for an extended period, often six months or longer. Monitoring for drug resistance is crucial, as non-compliance can lead to multidrug-resistant tuberculosis (MDR-TB). Public health implications are significant, as tuberculosis is a communicable disease requiring contact tracing and isolation procedures for active cases to prevent transmission. The management of tuberculosis of intrathoracic lymph nodes requires a multidisciplinary approach, including pulmonologists, infectious disease specialists, and public health officials.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with respiratory symptoms and a history of TB exposure.
Ensure thorough documentation of imaging results and microbiological tests.
Comprehensive records of treatment regimens, drug resistance testing, and patient follow-up.
Management of patients with complicated TB cases or those with drug-resistant strains.
Focus on public health implications and contact tracing efforts.
Used to evaluate suspected TB in the lungs and lymph nodes.
Document the reason for the X-ray and any findings.
Pulmonologists should ensure imaging correlates with clinical findings.
Common symptoms include persistent cough, fever, night sweats, weight loss, and chest pain. Patients may also experience respiratory distress depending on the extent of lymph node involvement.
